Inhaled Corticosteroids Market is Valued at USD 1,222.28 Million at a CAGR of 4.80% During the Forecast Period 2029

Kommentare · 459 Ansichten

Data Bridge Market Research analyses that the inhaled corticosteroids market was valued at USD 840 million in 2021 and is expected to reach USD 1,222.28 million by 2029, registering a CAGR of 4.80% during the forecast period 2029.

 

Data Bridge Market Research analyses that the inhaled corticosteroids market was valued at USD 840 million in 2021 and is expected to reach USD 1,222.28 million by 2029, registering a CAGR of 4.80% during the forecast period 2029.

Industry Analysis

As per the United Nations report 2020, the global population will grow from 7.2 billion to 8.2 billion by 2025. This, in turn, increases the frequency of chronic diseases across the globe. Along with this, the incidence rate of asthma among people is also rising. According to the world health organization (WHO) factsheet for 2021, asthma is a serious non-communicable disease (NCD) that affects both children and adults. Corticosteroids are commonly used to treat asthma. Therefore, these factors lead to the high demand of inhaled corticosteroids in the market.

The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Medicines containing corticosteroids such as beclomethasone, budesonide, ciclesonide, flunisolide, fluticasone, or mometasone in a composition designed to be inhaled through the mouth are known as inhaled corticosteroids. Inhaled corticosteroids limit the inflammatory process that causes asthma by acting directly in the lungs. Inhaled corticosteroids aid in the prevention of asthma attacks as well as the improvement of lung function. They may also be used to treat other lung diseases, such as chronic obstructive pulmonary disease (COPD).

Global Inhaled Corticosteroids Market Scope

The inhaled corticosteroids market is segmented on the basis of type, indication, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Beclomethasone Dipropionate
  • Budesonide
  • Fluticasone
  • Mometasone
  • Others

Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others

Dosage form

  • Aerosol Liquid
  • Aerosol Powder
  • Powder
  • Suspension

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-inhaled-corticosteroids-market

Inhaled Corticosteroids Market Regional Analysis/Insights

The inhaled corticosteroids market is analysed and market size insights and trends are provided by country, type, indication, dosage form, end-users and distribution channel as referenced above.

The countries covered in the Inhaled corticosteroids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the inhaled corticosteroids market because of the growing prevalence of chronic obstructive pulmonary disease (COPD), asthma and other upper respiratory infections in this region. Additionally the presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to surging prevalence of asthma and increasing number of geriatric population in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Inhaled Corticosteroids Market Share Analysis

The Inhaled corticosteroids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to inhaled corticosteroids market.

Some of the major players operating in the inhaled corticosteroids market are:

  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Boehringer Ingelheim International GmbH. (Germany)
  • AstraZeneca (UK)
  • Johnson Johnson Private Limited (US)
  • Bayer AG (Germany)
  • Merck Co., Inc. (US)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Bristol-Myers Squibb Company (US)
  • Amgen Inc. (US)
  • LEO Pharma A/S (Denmark)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Eli Lilly and Company (US)
  • Cipla Inc. (US)
  • Sumitomo Corporation (Japan)

Get Full Access of reports @ https://www.databridgemarketresearch.com/reports/global-inhaled-corticosteroids-market

MAJOR TOC OF THE REPORT

  • Chapter One: Introduction
  • Chapter Two: Market Segmentation
  • Chapter Three: Market Overview
  • Chapter Four: Executive Summary
  • Chapter Five: Premium Insights
  • Chapter Six: Global Inhaled Corticosteroids Market by Product Procedure type

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-inhaled-corticosteroids-market

Browse Related Reports @

https://www.databridgemarketresearch.com/reports/global-stretchers-market

https://www.databridgemarketresearch.com/reports/global-medical-oxygen-concentrators-and-oxygen-cylinders-market

https://www.databridgemarketresearch.com/reports/global-hair-transplant-market

https://www.databridgemarketresearch.com/reports/global-mens-health-market

https://www.databridgemarketresearch.com/reports/global-induced-pluripotent-stem-cells-market

About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818  
Email: Sopan.gedam@databridgemarketresearch.com